Skip to main content
Top
Published in: Neurological Sciences 3/2016

01-03-2016 | Original Article

Transcranial sonography in movement disorders: an interesting tool for diagnostic perspectives

Authors: E. Sanzaro, F. Iemolo

Published in: Neurological Sciences | Issue 3/2016

Login to get access

Abstract

Transcranial sonography has become an important tool for the diagnosis of various movement disorders. In most patients with idiopathic Parkinson disease, a markedly hyperechogenic substantia nigra (SN) was detected on at least one side. We have highlighted the sonographic features that might help the differential diagnosis of PD and other movement disorders. Our investigation involved 30 patients (age 45–85 years) with idiopathic Parkinson disease, 2 multiple system atrophy, 3 progressive supranuclear palsy and 2 patients with restless legs syndrome. In accordance with several previous studies, we detected hyperechogenicity of the SN by TCS in 90 % of patients with idiopathic Parkinson disease. Subjects with a marked severity disease had a larger extent of the hyperechogenic SN signal. All progressive supranuclear palsy patients had an enlarged third ventricle and, in two cases, we observed the presence of hyperechoic areas in the lentiform nucleus. This last ultrasonographic feature was also seen in our patients with multiple system atrophy. TCS abnormalities of the SN, midbrain raphe and basal ganglia are characteristics of several movement and affective disorders. These features are less easily detected by other techniques, such as CT and MRI, which enable the exclusion of structural lesions, such as tumours and multi-infarct disease, because the physical principle differs from other imaging methods.
Literature
1.
go back to reference Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76:423–425CrossRefPubMedPubMedCentral Behnke S, Berg D, Naumann M, Becker G (2005) Differentiation of Parkinson’s disease and atypical parkinsonian syndromes by transcranial ultrasound. J Neurol Neurosurg Psychiatry 76:423–425CrossRefPubMedPubMedCentral
2.
go back to reference Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044–1055CrossRefPubMed Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044–1055CrossRefPubMed
3.
go back to reference Kolevski G, Petrov I, Petrova V (2007) Transcranial sonography in the evaluation of Parkinson disease. J Ultrasound Med 26:509–512PubMed Kolevski G, Petrov I, Petrova V (2007) Transcranial sonography in the evaluation of Parkinson disease. J Ultrasound Med 26:509–512PubMed
4.
go back to reference Gaenslen A et al (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson’s disease: a prospective blinded study. Lancet Neurol 7:417–424CrossRefPubMed Gaenslen A et al (2008) The specificity and sensitivity of transcranial ultrasound in the differential diagnosis of Parkinson’s disease: a prospective blinded study. Lancet Neurol 7:417–424CrossRefPubMed
5.
go back to reference Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70:1411–1417CrossRefPubMed Martin WR, Wieler M, Gee M (2008) Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70:1411–1417CrossRefPubMed
6.
go back to reference Zecca L, Berg D, Arzberger T et al (2005) In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20(10):1278–1285CrossRefPubMed Zecca L, Berg D, Arzberger T et al (2005) In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage. Mov Disord 20(10):1278–1285CrossRefPubMed
7.
go back to reference Michell AW, Lewis SJG, Foltynie T, Barker RA (2004) Biomarkers and Parkinson’s disease. Brain 127:1693–1705CrossRefPubMed Michell AW, Lewis SJG, Foltynie T, Barker RA (2004) Biomarkers and Parkinson’s disease. Brain 127:1693–1705CrossRefPubMed
8.
go back to reference Spiegel J et al (2006) Transcranial sonography and [123I] FP-CIT SPECT disclose complementary aspects of Parkinson’s disease. Brain 129:1188–1193CrossRefPubMed Spiegel J et al (2006) Transcranial sonography and [123I] FP-CIT SPECT disclose complementary aspects of Parkinson’s disease. Brain 129:1188–1193CrossRefPubMed
9.
go back to reference Sanzaro E, Iemolo F, Duro G, Malferrari G (2014) A new assessment tool for Parkinson disease. The nigral lesion load obtained by transcranial sonography. J Ultrasound Med 33:1635–1640CrossRefPubMed Sanzaro E, Iemolo F, Duro G, Malferrari G (2014) A new assessment tool for Parkinson disease. The nigral lesion load obtained by transcranial sonography. J Ultrasound Med 33:1635–1640CrossRefPubMed
10.
go back to reference Rocchi L, Niccolini F, Politis M (2015) Recent imaging advances in neurology. J Neurol 262(9):2182–2194CrossRefPubMed Rocchi L, Niccolini F, Politis M (2015) Recent imaging advances in neurology. J Neurol 262(9):2182–2194CrossRefPubMed
Metadata
Title
Transcranial sonography in movement disorders: an interesting tool for diagnostic perspectives
Authors
E. Sanzaro
F. Iemolo
Publication date
01-03-2016
Publisher
Springer Milan
Published in
Neurological Sciences / Issue 3/2016
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-015-2424-6

Other articles of this Issue 3/2016

Neurological Sciences 3/2016 Go to the issue